[Monitoring the effectiveness of conservative treatment of benign prostatic hypertrophy by means of uroflowmetry].
96 patients with benign hyperplasia of the prostate and dysuric complaints in stage I and beginning stage II were treated conservatively and medicamentously up to 12 months. In the collective of patients subdivided into 4 groups the conservative therapy was carried out in 3 groups with different phyto-preparations and in one group with gestonorone capromate. The voiding of the bladder was examined by means of uroflowmetry in intervals of four weeks before and after therapy. A clear success of the effect appeared only in the group of patients treated with gestonorone capromate. With phyto-preparations uroflowmetrically no significant effect on the disturbed voiding of the bladder could be established. The conservative treatment of the benign hyperplasia of the prostate should be carried out under uroflowmetrical control, in order not to miss the time of a necessary operative intervention.
D000368:Aged; D000470:Alkaloids / Q000627:therapeutic use*; D005500:Follow-Up Studies; D005866:Gestonorone Caproate / Q000627:therapeutic use*; D006801:Humans; D007734:Kymography; D008297:Male; D008875:Middle Aged; D009662:Nortropanes / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D010936:Plant Extracts / Q000627:therapeutic use; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000188:drug therapy*; D011759:Pyrrolidines / Q000627:therapeutic use*; D012855:Sitosterols / Q000627:therapeutic use*; D014556:Urine
D000470:Alkaloids; D009662:Nortropanes; D010880:Piperidines; D010936:Plant Extracts; D011759:Pyrrolidines; D012855:Sitosterols; D005866:Gestonorone Caproate
Untersuchungen zum Wirkungserfolg der konservativen Behandlung bei benigner Prostatahyperplasie durch Uroflowmetrie.